THE ULTIMATE GUIDE TO MBO128

Emily Bodnar’s rating relies about the anticipation of sizeable milestones for Agenus in the coming calendar year, particularly the potential filing of a Biologics License Application (BLA) for their lead drug candidate, botensilimab (bot). Agenus has dosed over 900 sufferers with bot across numerous reliable tumors, demonstrating a dedication to